Vical Provides Company Update at Biocom's Global Life Science Partnering Conference
February 24 2017 - 3:00PM
Vical Incorporated (Nasdaq:VICL) today announced that the company
will provide an overview of its technologies, development programs,
and outlook at 2:15 p.m. PT on Thursday, March 2, at Biocom's
Global Life Science Partnering Conference (La Jolla – March
1-2). A copy of the presentation will be available through
the Events & Presentations page in the Investors section of the
Vical website at www.vical.com.
About VicalVical develops
biopharmaceutical products for the prevention and treatment of
chronic or life-threatening infectious diseases, based on its
patented DNA delivery technologies and other therapeutic
approaches. Additional information on Vical is available at
www.vical.com.
Contact:
Tony Ramos
(858) 646-1127
Website: www.vical.com
Vical (NASDAQ:VICL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vical (NASDAQ:VICL)
Historical Stock Chart
From Sep 2023 to Sep 2024
